Literature DB >> 23444898

Gene polymorphisms, tobacco exposure and oral cancer susceptibility: a study from Gujarat, West India.

R D Singh1, N Haridas, F D Shah, J B Patel, S N Shukla, P S Patel.   

Abstract

Polymorphic variability in the enzymes involved in biotransformation of tobacco-related pro-carcinogens plays an important role in modulating oral cancer susceptibility. CYP1A1*2A, CYP1A1*2C, GSTM1 and GSTT1 polymorphisms were determined in 122 oral carcinoma cases and 127 controls from Gujarat, West India using PCR-based methods. The results revealed that the polymorphic variants of CYP1A1 gene did not show association towards oral cancer risk. The GSTM1 and GSTT1 null genotypes were found to be over-represented in patients than controls, suggesting a moderate increase in risk of oral cancer. The oral cancer risk was significantly increased in the patients having either alone or concurrent deletion of GSTM1 and GSTT1. The results also suggested significant association between tobacco habits, especially chewing, variant genotypes of CYP1A1, GSTM1 and GSTT1 and oral cancer risk. Our data have provided evidence that GST polymorphism modified the susceptibility to oral cancer and individuals with variant genotypes of the three genes with tobacco habits are at significant risk of developing oral cancer.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CYP1A1; GST; oral cancer; polymorphism

Mesh:

Substances:

Year:  2013        PMID: 23444898     DOI: 10.1111/odi.12079

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  10 in total

1.  GSTM1 null polymorphisms and oral cancer risk: a meta-analysis.

Authors:  Su-Feng Zhao; Xu-Dong Yang; Ming-Xing Lu; Guo-Wen Sun; Yu-Xin Wang; Yin-Kai Zhang; Yu-Mei Pu; En-Yi Tang
Journal:  Tumour Biol       Date:  2013-07-31

2.  CYP1A1 polymorphism interactions with smoking status in oral cancer risk: evidence from epidemiological studies.

Authors:  Kai-Tao Yu; Cheng Ge; Xiao-Fang Xu; Jing-Cai Zou; Xuan Zou; Shuai Zhen
Journal:  Tumour Biol       Date:  2014-08-09

3.  Evidence of Association of CYP1A1 Expression in Blood Lymphocytes and Clinicopathological Variables in Oral Cancer.

Authors:  R D Singh; K A Patel; J B Patel; S J Pandya; P S Patel
Journal:  Indian J Clin Biochem       Date:  2021-02-12

4.  Gene polymorphisms and oral cancer risk in tobacco habitués.

Authors:  Shaleen Multani; Sultan Pradhan; Dhananjaya Saranath
Journal:  Tumour Biol       Date:  2015-11-27

Review 5.  Genotypic distribution of single nucleotide polymorphisms in oral cancer: global scene.

Authors:  Shaleen Multani; Dhananjaya Saranath
Journal:  Tumour Biol       Date:  2016-09-20

6.  Dental Procedures, Oral Practices, and Associated Anxiety: A Study on Late-teenagers.

Authors:  Rahul Bhola; Reema Malhotra
Journal:  Osong Public Health Res Perspect       Date:  2014-07-01

7.  The association of the CYP1A1 Ile462Val polymorphism with head and neck cancer risk: evidence based on a cumulative meta-analysis.

Authors:  Yadong Wang; Haiyan Yang; Guangcai Duan; Haiyu Wang
Journal:  Onco Targets Ther       Date:  2016-05-17       Impact factor: 4.147

8.  Association between the CYP1A1 MspI polymorphism and risk of head and neck cancer: a meta-analysis.

Authors:  Hady Mohammadi; Mehrnoush Momeni Roochi; Farzad Rezaei; Ata Garajei; Hosein Heidar; Bayazid Ghaderi; Masoud Sadeghi
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

9.  The Fagerström and AUDIT Tests as Probable Screening Tools in Oral Cancer and Their Correlation with CYP1A1, GSTM1, GSTP1, and GSTT1 Gene Expression.

Authors:  Celso Muller Bandeira; Adriana Ávila Almeida; Mônica Ghislaine Oliveira Alves; Maria Beatriz Nogueira Pascoal; José Francisco Sales Chagas; Morun Bernardino Neto; Patrícia Pimentel de Barros; Fábio Daumas Nunes; Celina Faig Lima Carta; Janete Dias Almeida
Journal:  Int J Environ Res Public Health       Date:  2022-03-27       Impact factor: 3.390

10.  Association between CYP1A1 Ile462Val Polymorphism and Oral Squamous Cell Carcinoma Susceptibility: Evidence from 13 Investigations.

Authors:  Xiao-Lei Yang; Shang Xie; Yi-Yan Jiang; Chang Shi; Zhi-Gang Cai; Su-Xiu Chen
Journal:  J Cancer       Date:  2015-01-22       Impact factor: 4.207

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.